Thromboxane b2

Thromboxane b2 is a lipid of Fatty Acyls (FA) class. Thromboxane b2 is associated with abnormalities such as endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia and Thrombocytosis. The involved functions are known as Platelet Activation, Excretory function, Anabolism, Inflammation and mRNA Expression. Thromboxane b2 often locates in Endothelium, Hepatic and Microsomes, Liver. The associated genes with Thromboxane b2 are PTGS2 gene, prothrombin fragment 2 and CCL14 wt Allele.

Cross Reference

Introduction

To understand associated biological information of Thromboxane b2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Thromboxane b2?

Thromboxane b2 is suspected in endothelial dysfunction, Diabetes Mellitus, Non-Insulin-Dependent, Diabetes Mellitus, Ischemia, Thrombocytosis, Acute Coronary Syndrome and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Thromboxane b2

MeSH term MeSH ID Detail
Latex Hypersensitivity D020315 1 associated lipids
Stroke D020521 32 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Coronary Stenosis D023921 6 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Cholecystitis, Acute D041881 1 associated lipids
Dyslipidemias D050171 7 associated lipids
Atherosclerosis D050197 85 associated lipids
Hypoalphalipoproteinemias D052456 5 associated lipids
Per page 10 20 50 100 | Total 293

PubChem Associated disorders and diseases

What pathways are associated with Thromboxane b2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Thromboxane b2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Thromboxane b2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

What genes are associated with Thromboxane b2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Thromboxane b2?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Thromboxane b2

Download all related citations
Per page 10 20 50 100 | Total 6367
Authors Title Published Journal PubMed Link
Diczfalusy U et al. Peroxisomal chain-shortening of thromboxane B2: evidence for impaired degradation of thromboxane B2 in Zellweger syndrome. 1993 J. Lipid Res. pmid:8371058
Takasaki W et al. Superiority of plasma 11-dehydro-TXB2 to TXB2 as an index of in vivo TX formation in rabbits after dosing of CS-518, a TX synthase inhibitor. 1993 Thromb. Res. pmid:8367836
de la Cruz JP et al. Antiplatelet effect of pentoxifylline in human whole blood. 1993 Gen. Pharmacol. pmid:8365640
Mounier C et al. Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activation. 1993 Eur. J. Biochem. pmid:8365403
Gow JA et al. The effect of regular and enteric-coated aspirin on bleeding time, thromboxane, and prostacyclin. 1993 Prostaglandins Leukot. Essent. Fatty Acids pmid:8361987
Sumiya T et al. Effects of reactive oxygen species on arachidonic acid metabolism in rabbit platelets. 1993 Free Radic. Biol. Med. pmid:8359708
Chu ZM and Beilin LJ Mechanisms of vasodilatation in pregnancy: studies of the role of prostaglandins and nitric-oxide in changes of vascular reactivity in the in situ blood perfused mesentery of pregnant rats. 1993 Br. J. Pharmacol. pmid:8358537
Aziz SM et al. Intrinsic microbicidal activity and pulmonary hypertension in isolated newborn piglet lungs. 1993 Pediatr. Res. pmid:8356015
Capaz FR et al. Effect of active sensitization on the bronchopulmonary responses to tachykinins in the guinea pig. Modulation by peptidase inhibitors. 1993 J. Pharmacol. Exp. Ther. pmid:8355211
Qu J and Thomas K Prostaglandins stimulate the secretion of inhibin from human placental cells. 1993 J. Clin. Endocrinol. Metab. pmid:8345062
Horgan PG et al. Extracorporeal shock wave lithotripsy induces the release of prostaglandins which increase ureteric peristalsis. 1993 Br J Urol pmid:8343888
Vissinger H et al. Platelet-derived growth factor release and antiplatelet treatment with low-dose acetylsalicylic acid. 1993 Angiology pmid:8342880
Beitz A et al. Lipoproteins from normolipidemic and dyslipidemic subjects modify the thromboxane A2 generation by platelets in clotting human blood. 1993 Prostaglandins Leukot. Essent. Fatty Acids pmid:8341726
Ritter JM et al. Thromboxane A2 receptor antagonism and synthase inhibition in essential hypertension. 1993 Hypertension pmid:8340155
Loick HM et al. Thromboxane receptor blockade with BM 13,177 following toxic airway damage by smoke inhalation in sheep. 1993 Eur. J. Pharmacol. pmid:8339755
Tesson F et al. Cell-associated and soluble phospholipases A2 increase during carrageenan and zymosan-induced pleurisy in rat. 1993 Eur. J. Pharmacol. pmid:8339752
Keimowitz RM et al. Transdermal modification of platelet function. A dermal aspirin preparation selectively inhibits platelet cyclooxygenase and preserves prostacyclin biosynthesis. 1993 Circulation pmid:8339418
Wang SR et al. [Experimental study on effects of 18 kinds of Chinese herbal medicine for synthesis of thromboxane A2 and PGI2]. 1993 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8339039
Ford I et al. Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. 1993 Br. J. Haematol. pmid:8338784
Gu YJ et al. Biocompatibility of leukocyte removal filters during leukocyte filtration of cardiopulmonary bypass perfusate. 1993 Artif Organs pmid:8338443
Wetzka B et al. Eicosanoid production by intrauterine tissues before and after labor in short-term tissue culture. 1993 Prostaglandins pmid:8337416
Keith JC et al. Effects of ridogrel on the prostacyclin-thromboxane ratio in nulliparous third trimester-pregnant rhesus monkeys. 1993 Prostaglandins pmid:8337414
Myers SI et al. Burn injury decreased splanchnic PGI2 release is restored by treatment with lazaroid. 1993 Prostaglandins pmid:8337413
Mahmoud TZ et al. Correlation between umbilical artery resistance index, 6 ketoprostaglandin F1 alpha and thromboxane B2 in the fetoplacental compartment in patients with pregnancy induced hypertension. 1993 Prostaglandins pmid:8337411
Vollmar B et al. Heparin-protamine reactions in pigs: role of oxygen-derived free radicals. 1993 J. Appl. Physiol. pmid:8335575
Kraayenbrink AA et al. Endothelial vasoactive mediators in preeclampsia. 1993 Am. J. Obstet. Gynecol. pmid:8333445
Rouse DJ et al. Midpregnancy serum thromboxane B2 determinations do not predict subsequent adverse pregnancy outcomes. 1993 Am. J. Obstet. Gynecol. pmid:8333431
Weiss HJ and Lages B Studies of thromboxane B2, platelet factor 4, and fibrinopeptide A in bleeding-time blood of patients deficient in von Willebrand factor, platelet glycoproteins Ib and IIb-IIIa, and storage granules. 1993 Blood pmid:8329704
Patterson WR et al. Aggregation of killer whale platelets. 1993 Thromb. Res. pmid:8327987
Lemne C et al. Plasma growth factor activity and cardiac wall thickness. 1993 J. Intern. Med. pmid:8326295
Ohara N et al. Tissue eicosanoids and vascular permeability in rats with chronic biliary obstruction. 1993 Hepatology pmid:8325602
Chiabrando C et al. Urinary excretion and origin of 11-dehydro-2,3-dinor-thromboxane B2 in man. 1993 Prostaglandins pmid:8321910
Peredo HA and Enero MA Effect of endothelium removal on basal and muscarinic cholinergic stimulated rat mesenteric vascular bed prostanoid synthesis. 1993 Prostaglandins Leukot. Essent. Fatty Acids pmid:8321873
van Pampus EC et al. Influence of aspirin on human megakaryocyte prostaglandin synthesis. 1993 Eur. J. Haematol. pmid:8319788
Olson RW et al. Beneficial effects of combined thromboxane synthase inhibition/receptor blockade with CGS 22652 in a canine model of coronary thrombosis. 1993 Eur. J. Pharmacol. pmid:8319746
Swaim SF et al. The greyhound dog as a model for studying pressure ulcers. 1993 Decubitus pmid:8318156
Li JX et al. Capsular type-specific polysaccharide partially inhibits group B Streptococcus-induced pulmonary hypertension. 1993 Am. Rev. Respir. Dis. pmid:8317791
Romero R et al. The relationship between spontaneous rupture of membranes, labor, and microbial invasion of the amniotic cavity and amniotic fluid concentrations of prostaglandins and thromboxane B2 in term pregnancy. 1993 Am. J. Obstet. Gynecol. pmid:8317506
Hudson N et al. Effect of Helicobacter pylori colonisation on gastric mucosal eicosanoid synthesis in patients taking non-steroidal anti-inflammatory drugs. 1993 Gut pmid:8314505
Schumacher WA et al. Comparison of a thromboxane receptor antagonist and aspirin in experimental arterial thrombosis. 1993 Jul-Aug Haemostasis pmid:8314172
Randomized trial of ridogrel, a combined thromboxane A2 synthase inhibitor and thromboxane A2/prostaglandin endoperoxide receptor antagonist, versus aspirin as adjunct to thrombolysis in patients with acute myocardial infarction. The Ridogrel Versus Aspirin Patency Trial (RAPT). 1994 Circulation pmid:8313547
Yuan W [Changes in renal cortical thromboxane A2, prostaglandin F1 alpha and effects of dazoxiben, chuan xiong on in situ immune complex glomerulonephritis in rats]. 1993 Zhonghua Yi Xue Za Zhi pmid:8313194
Huang YS [Thromboxane and prostacyclin imbalance in the pathogenesis of early damage after severe burns]. 1993 Zhonghua Yi Xue Za Zhi pmid:8313186
Napolov IuK et al. [The effect of x-ray contrast media on the amount of thromboxane and prostacyclin in the blood of man and rats in vivo and in vitro]. 1993 Sep-Oct Eksp Klin Farmakol pmid:8312809
Wang XP et al. [Therapeutic effects and mechanisms of tetramethylpyrazine on lung injury in acute haemorrhagic necrotizing pancreatitis in rats]. 1993 Zhongguo Zhong Xi Yi Jie He Za Zhi pmid:8312699
Edwin SS et al. Cyclosporin A attenuates increased prostaglandin and thromboxane production in response to various stimuli in human decidua. 1993 Sep-Oct Am. J. Reprod. Immunol. pmid:8311924
Bashakin NF et al. [The functional characteristics of the prostacyclin-thromboxane system in newborn infants with a history of acute and chronic intrauterine hypoxia]. 1993 Akush Ginekol (Mosk) pmid:8311150
Suckfüll MM et al. The contribution of endothelial cells to hyperacute rejection in xenogeneic perfused working hearts. 1994 Transplantation pmid:8310518
Foegh ML et al. Urinary thromboxane A2 metabolites in patients presenting in the emergency room with acute chest pain. 1994 J. Intern. Med. pmid:8308478
Schuster DP et al. Thromboxane receptor stimulation/inhibition and perfusion redistribution after acute lung injury. 1993 J. Appl. Physiol. pmid:8307861